Skip to main content

Gilead Takes Over Federal Authorities For HIV Drug Patents

Gilead Takes Over Federal Authorities For HIV Drug Patents

Gilead Takes Over Federal Authorities For HIV Drug Patents

Introduction

Manufacturers of HIV drug Truvada, Gilead Sciences, filed a lawsuit against the U.S. government, alleging that the U.S. Centers for Disease Control and Prevention (CDC) violated a contract, governing the collaboration on HIV drug, between the company and government agency.

According to the lawsuit filed, the manufacturer indicated that the U.S. government violated four Material Transfer Agreements (MTAs) and a Clinical Trial Agreement between the company and the CDC. Gilead initially received approval from the FDA for the use of drugs combined with other treatments. However, as per the lawsuit, in the early 2000s, researchers at CDC created new regimens, patented by the U.S. government, to prevent the spread of HIV.

Last year, in November 2019, the U.S. Department of Justice filed a lawsuit, claiming that the government spent hundreds of millions of dollars on clinical studies, and Gilead profited by selling the drugs at highly inflated prices.

The recent case is the latest rift between the federal government and Gilead, over who owns the patent for the HIV drug.

Along with the legal dispute with the Justice Department, Gilead is also facing an increasing number of complaints filed by plaintiffs nationwide, alleging side effects of tenofovir disoproxil fumarate (TDF) infused HIV drugs like Truvada, Stribild, and other medications.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.